Search Results for HODGKIN'S LYMPHOMA

330-339
The risk-adaptive strategies of Hodgkin's lymphoma therapy
15.12.2016
https://doi.org/10.37469/0507-3758-2016-62-2-330-339
625-629
Immunohistochemical prognostic factors of primary refractory Hodgkin’s lymphoma
15.12.2014
https://doi.org/10.37469/0507-3758-2014-60-5-625-629
285-289
Creation of a statistical model for prediction of Hodgkin's lymphoma in young adults
15.12.2016
https://doi.org/10.37469/0507-3758-2016-62-2-285-289
59-65
The efficacy and toxicity of programs MOPP, ABVD, BEACOPP-base in primary Hodgkin’s lymphoma patients with a poor prognosis
15.12.2013
https://doi.org/10.37469/0507-3758-2013-59-2-59-65
832-840
The value of high-technology methods of radiodiagnosis in oncology
15.12.2012
https://doi.org/10.37469/0507-3758-2012-58-6-832-840
Kristina Arturovna Komissarova, Timur Raisovich Izmailov
OF-2364
Clinical Case of an Abscopal Effect in a Patient with Hodgkin's Lymphoma Treated with Checkpoint Inhibition and Radiotherapy
05.11.2025
https://doi.org/10.37469/0507-3758-2025-71-5-OF-2364
Sergey Alekseev, Yevgeniya Kharchenko, Svetlana Kuleva, Tatyana Semiglazova
419-428
MODERN THERAPY FOR RELAPSES AND RESISTANT FORMS OF HODGKIN''S LYMPHOMA
01.03.2018
https://doi.org/10.37469/0507-3758-2018-64-3-419-428
360-365
Evaluation of ovarian status in women who received anti-tumor therapy in childhood and adolescence
15.12.2014
https://doi.org/10.37469/0507-3758-2014-60-3-360-365
444-452
THE CELLULAR MICROENVIRONMENT OF MALIGNANT TUMORS AND ITS SIGNIFICANCE IN THEIR PROGNOSIS
15.12.2013
https://doi.org/10.37469/0507-3758-2013-59-4-444-452
700-706
Dendritic cells activated by cancer-testis antigens (CTA+) in treatment of metastatic soft tissue sarcomas
15.12.2014
https://doi.org/10.37469/0507-3758-2014-60-6-700-706
731-734
Effect of paraneoplastic rheumatic syndrome in lung cancer patients on tumor expression of BCL-2
15.12.2013
https://doi.org/10.37469/0507-3758-2013-59-6-731-734

Search Parameters